Liaoning Chengda Biotechnology Co., Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 19.86
+0.37 (1.90%)
At close: Jul 10, 2026
SHA:688739 Market Cap
SHA:688739 has a market cap or net worth of 8.17 billion as of July 10, 2026. Its market cap has decreased by -22.71% in one year.
Market Cap
8.17B
Enterprise Value
3.09B
Revenue
1.31B
Ranking
n/a
PE Ratio
139.16
Stock Price
19.86
Market Cap Chart
Since October 28, 2021, SHA:688739's market cap has decreased from 33.32B to 8.17B, a decrease of -75.48%. That is a compound annual growth rate of -25.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 8.17B | -22.90% |
| Dec 31, 2025 | 10.59B | -0.17% |
| Dec 31, 2024 | 10.61B | -21.62% |
| Dec 29, 2023 | 13.54B | 6.87% |
| Dec 30, 2022 | 12.67B | -60.04% |
| Dec 31, 2021 | 31.70B | -4.84% |
| Oct 28, 2021 | 33.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Genrix Biopharmaceutical | 9.05B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.02B |
| Pacific Shuanglin Bio-pharmacy | 8.76B |
| Sino Biological,Inc. | 8.52B |
| Acrobiosystems | 8.46B |
| Vcanbio Cell & Gene Engineering Corp., | 8.37B |
| Aurisco Pharmaceutical | 8.15B |
| Bio-Thera Solutions | 7.72B |